About Spore Biotechnologies
Spore Biotechnologies is a company based in Paris (France) founded in 2022 by Amine Raji and Maxime Mistretta.. Spore Biotechnologies has raised $31.61 million across 3 funding rounds from investors including STATION F, Singular and Point72 Ventures. Spore Biotechnologies offers products and services including AI Microbiology Technology. Spore Biotechnologies operates in a competitive market with competitors including AFYREN, Biopsin, Mesosil, Celsis and Source Molecular, among others.
- Headquarter Paris, France
- Founders Amine Raji, Maxime Mistretta
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$31.61 M (USD)
in 3 rounds
-
Latest Funding Round
-
Investors
STATION F
& 12 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Spore Biotechnologies
Spore Biotechnologies offers a comprehensive portfolio of products and services, including AI Microbiology Technology. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
AI tool for rapid microbiology analysis and diagnostics
Unlock access to complete
Funding Insights of Spore Biotechnologies
Spore Biotechnologies has successfully raised a total of $31.61M across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Last Round
-
First Round
First Round
(12 Dec 2023)
- Investors Count 13
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2026 | Amount | Grant - Spore Biotechnologies | Valuation |
investors |
|
| Feb, 2025 | Amount | Series A - Spore Biotechnologies | Valuation | Singular | |
| Dec, 2023 | Amount | Seed - Spore Biotechnologies | Valuation | LocalGlobe |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Spore Biotechnologies
Spore Biotechnologies has secured backing from 13 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include STATION F, Singular and Point72 Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage venture capital investments are made in European startups.
|
Founded Year | Domain | Location | |
|
Venture capital fund focused on seed to growth stage fintech, deep tech, and enterprise tech companies
|
Founded Year | Domain | Location | |
|
Startups are accelerated and incubated via structured programs.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Spore Biotechnologies
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Spore Biotechnologies
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Spore Biotechnologies Comparisons
Competitors of Spore Biotechnologies
Spore Biotechnologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AFYREN, Biopsin, Mesosil, Celsis and Source Molecular, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Analytical services are provided for microbiology, chemistry, and bioprocesses sectors.
|
|
| domain | founded_year | HQ Location |
Real-time microbial detection system is developed for product testing.
|
|
| domain | founded_year | HQ Location |
Antimicrobial materials are developed for infection prevention in medical devices.
|
|
| domain | founded_year | HQ Location |
Rapid microbial screening systems are manufactured for quality control testing.
|
|
| domain | founded_year | HQ Location |
Technology for microbial source tracking is provided by Source Molecular.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Spore Biotechnologies
Frequently Asked Questions about Spore Biotechnologies
When was Spore Biotechnologies founded?
Spore Biotechnologies was founded in 2022 and raised its 1st funding round 1 year after it was founded.
Where is Spore Biotechnologies located?
Spore Biotechnologies is headquartered in Paris, France.
Who is the current CEO of Spore Biotechnologies?
Amine Raji is the current CEO of Spore Biotechnologies. They have also founded this company.
Is Spore Biotechnologies a funded company?
Spore Biotechnologies is a funded company, having raised a total of $31.61M across 3 funding rounds to date. The company's 1st funding round was a Seed of $8.61M, raised on Dec 12, 2023.
What does Spore Biotechnologies do?
Spore Biotechnologies was founded in 2022 and is based in Paris, France. Bacterial and microbial risks are detected through technologies tailored for food and beverage, cosmetics, and pharmaceuticals sectors within life sciences. Operations center on creating detection solutions to support manufacturers in risk assessment and compliance. The company is led by co-founders Amine Raji as CEO and Maxime Mistretta.
Who are the top competitors of Spore Biotechnologies?
What products or services does Spore Biotechnologies offer?
Spore Biotechnologies offers AI Microbiology Technology.
Who are Spore Biotechnologies's investors?
Spore Biotechnologies has 13 investors. Key investors include STATION F, Singular, Point72 Ventures, No Label Ventures, and Famille C Participations.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.